Indian group applies for emergency use authorization of COVAXIN in PH enablePagination: false (FILE PHOTO) Metro Manila (CNN Philippines, January 21) — An Indian group has applied for emergency use authorization for COVAXIN, making it the fourth brand of COVID-19 vaccine to seek approval for distribution in the country. "Ambica International Corporation and Family Vaccine (FVSC) and specialty clinics (through IP Biotech) has filed for emergency use authorization (EUA) for COVAXIN, India's indigenous vaccine in the Philippines," a statement released on Thursday said. The EUA was filed with the Food and Drug Administration on Wednesday, it also said. According to the statement, FVSC and Ambica International Corporation consortium signed an agreement with Bharat Biotech International Ltd., the developer of the vaccine, to distribute COVAXIN should it meet FDA standards.